Trials / Completed
CompletedNCT02063360
DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)
Open-Label, Single-Sequence Study to Evaluate the Pharmacokinetic Interaction of BMS-663068 With Darunavir/Ritonavir and/or Etravirine in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if there is an interaction in healthy subjects taking BMS-663068 with Darunavir/Ritonavir and/or Etravirine.
Detailed description
Brief title: drug-drug interaction (DDI) Primary Purpose: Other : Phase 1 Clinical Pharmacology drug interaction study in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-663068 | BMS-663068 |
| DRUG | Darunavir (DRV) | Darunavir (DRV) |
| DRUG | Ritonavir (RTV) | Ritonavir (RTV) |
| DRUG | Etravirine (ETR) | Etravirine (ETR) |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-13
- First posted
- 2014-02-14
- Last updated
- 2017-08-08
Source: ClinicalTrials.gov record NCT02063360. Inclusion in this directory is not an endorsement.